Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$12.87 - $19.09 $180 - $267
-14 Reduced 0.14%
10,030 $189,000
Q3 2023

Nov 09, 2023

SELL
$15.0 - $22.17 $17,190 - $25,406
-1,146 Reduced 10.24%
10,044 $151,000
Q2 2023

Aug 11, 2023

SELL
$21.6 - $30.69 $12,765 - $18,137
-591 Reduced 5.02%
11,190 $241,000
Q1 2023

May 04, 2023

SELL
$23.07 - $32.77 $7,843 - $11,141
-340 Reduced 2.81%
11,781 $331,000
Q4 2022

Feb 10, 2023

BUY
$25.29 - $35.48 $15,705 - $22,033
621 Added 5.4%
12,121 $306,000
Q3 2022

Nov 08, 2022

BUY
$24.0 - $33.42 $43,008 - $59,888
1,792 Added 18.46%
11,500 $331,000
Q2 2022

Aug 10, 2022

BUY
$24.78 - $33.36 $240,564 - $323,858
9,708 New
9,708 $246,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.